On August 8, 2022, Atara Biotherapeutics, Inc. announced a reduction in its workforce plan that will impact approximately 20% of its current employees. The Company expects to substantially complete the workforce reduction by October 7, 2022. In connection with the reduction in workforce, the employment of Kristin Yarema, the Company's Senior Vice President and Chief Commercial Officer, will terminate effective as of November 15, 2022.